RECRUITING

The Avenues Study: Dual Use Cessation

Talk to us

Conditions

Smoking CessationElectronic Cigarette UseENDSCessation

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching goal of this research is to determine the most effective approach for helping dual users of cigarettes and electronic nicotine delivery systems (ENDS) quit smoking. 500 participants will be enrolled and can expect to be on study for 12 months.

Official Title

Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape

Quick Facts

Study Start:2024-09-24
Study Completion:2028-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06474299

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Able to read and communicate in English
  2. * Willing to set a quit date to quit smoking cigarettes in the next 30 days
  3. * Willing and medically able to use varenicline and nicotine patches
  4. * Smoking ≥ 5 cigarettes per day for the past 6 months
  5. * Vaping weekly for at least 6 months
  6. * Willing to stop using nicotine replacement or varenicline
  7. * Willing to stop using bupropion (i.e., Wellbutrin, Zyban) if they are currently using it only for smoking cessation
  1. * Plans to move out of the area for the next 12 months
  2. * Currently in treatment for psychosis or bipolar disorder
  3. * If they are currently taking bupropion for non-smoking cessation reasons (e.g., Wellbutrin for depression)
  4. * Currently pregnant or breastfeeding. If a participant becomes pregnant while in the study, they will be allowed to continue in the study but will no longer receive study medications. They will also be asked to return any unused study medications.

Contacts and Locations

Study Contact

Mark Zehner
CONTACT
608-262-7568
mark.zehner@wisc.edu

Principal Investigator

Megan E Piper, PhD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, 53792
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Megan E Piper, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-24
Study Completion Date2028-07

Study Record Updates

Study Start Date2024-09-24
Study Completion Date2028-07

Terms related to this study

Keywords Provided by Researchers

  • ENDS
  • Cessation

Additional Relevant MeSH Terms

  • Smoking Cessation
  • Electronic Cigarette Use